Female Infertility Drugs Market
1 Study Coverage
1.1 Female Infertility Drugs Product Introduction
1.2 Global Female Infertility Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Female Infertility Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Female Infertility Drugs Sales in Volume for the Year 2017-2028
1.3 United States Female Infertility Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Female Infertility Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Female Infertility Drugs Sales in Volume for the Year 2017-2028
1.4 Female Infertility Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Female Infertility Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Female Infertility Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Female Infertility Drugs Market Dynamics
1.5.1 Female Infertility Drugs Industry Trends
1.5.2 Female Infertility Drugs Market Drivers
1.5.3 Female Infertility Drugs Market Challenges
1.5.4 Female Infertility Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Female Infertility Drugs Market Segment by Type
2.1.1 Parenteral
2.1.2 Oral
2.1.3 Others
2.2 Global Female Infertility Drugs Market Size by Type
2.2.1 Global Female Infertility Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Female Infertility Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Female Infertility Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Female Infertility Drugs Market Size by Type
2.3.1 United States Female Infertility Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Female Infertility Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Female Infertility Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Female Infertility Drugs Market Segment by Application
3.1.1 Fertility Clinics
3.1.2 Hospitals
3.1.3 Cryobanks
3.2 Global Female Infertility Drugs Market Size by Application
3.2.1 Global Female Infertility Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Female Infertility Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Female Infertility Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Female Infertility Drugs Market Size by Application
3.3.1 United States Female Infertility Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Female Infertility Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Female Infertility Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Female Infertility Drugs Competitor Landscape by Company
4.1 Global Female Infertility Drugs Market Size by Company
4.1.1 Top Global Female Infertility Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Female Infertility Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Female Infertility Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Female Infertility Drugs Price by Manufacturer (2017-2022)
4.2 Global Female Infertility Drugs Concentration Ratio (CR)
4.2.1 Female Infertility Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Female Infertility Drugs in 2021
4.2.3 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Female Infertility Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Female Infertility Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Female Infertility Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Female Infertility Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Female Infertility Drugs Market Size by Company
4.5.1 Top Female Infertility Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Female Infertility Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Female Infertility Drugs Sales by Players (2020, 2021 & 2022)
5 Global Female Infertility Drugs Market Size by Region
5.1 Global Female Infertility Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Female Infertility Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Female Infertility Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Female Infertility Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Female Infertility Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Female Infertility Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Female Infertility Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Female Infertility Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Female Infertility Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Female Infertility Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Female Infertility Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Female Infertility Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Female Infertility Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Female Infertility Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Female Infertility Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Female Infertility Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Female Infertility Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan Plc
7.1.1 Allergan Plc Corporation Information
7.1.2 Allergan Plc Description and Business Overview
7.1.3 Allergan Plc Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Allergan Plc Female Infertility Drugs Products Offered
7.1.5 Allergan Plc Recent Development
7.2 Ferring BV
7.2.1 Ferring BV Corporation Information
7.2.2 Ferring BV Description and Business Overview
7.2.3 Ferring BV Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Ferring BV Female Infertility Drugs Products Offered
7.2.5 Ferring BV Recent Development
7.3 Merck KGaA
7.3.1 Merck KGaA Corporation Information
7.3.2 Merck KGaA Description and Business Overview
7.3.3 Merck KGaA Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck KGaA Female Infertility Drugs Products Offered
7.3.5 Merck KGaA Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG Female Infertility Drugs Products Offered
7.4.5 Novartis AG Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Female Infertility Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Female Infertility Drugs Products Offered
7.5.5 Sanofi Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Female Infertility Drugs Industry Chain Analysis
8.2 Female Infertility Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Female Infertility Drugs Distributors
8.3 Female Infertility Drugs Production Mode & Process
8.4 Female Infertility Drugs Sales and Marketing
8.4.1 Female Infertility Drugs Sales Channels
8.4.2 Female Infertility Drugs Distributors
8.5 Female Infertility Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Female Infertility Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Female Infertility Drugs Market Trends
Table 3. Female Infertility Drugs Market Drivers
Table 4. Female Infertility Drugs Market Challenges
Table 5. Female Infertility Drugs Market Restraints
Table 6. Global Female Infertility Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Female Infertility Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Female Infertility Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Female Infertility Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Female Infertility Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Female Infertility Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Female Infertility Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Female Infertility Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Female Infertility Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Female Infertility Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Female Infertility Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Female Infertility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2021)
Table 18. Top Players of Female Infertility Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Female Infertility Drugs Product Type
Table 20. Date of International Manufacturers Enter into Female Infertility Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Female Infertility Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Female Infertility Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Female Infertility Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Female Infertility Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Female Infertility Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Female Infertility Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Female Infertility Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Female Infertility Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Female Infertility Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Female Infertility Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Female Infertility Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Female Infertility Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Female Infertility Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Female Infertility Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Female Infertility Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Female Infertility Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Female Infertility Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Female Infertility Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Female Infertility Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Female Infertility Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Allergan Plc Corporation Information
Table 43. Allergan Plc Description and Business Overview
Table 44. Allergan Plc Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Allergan Plc Female Infertility Drugs Product
Table 46. Allergan Plc Recent Development
Table 47. Ferring BV Corporation Information
Table 48. Ferring BV Description and Business Overview
Table 49. Ferring BV Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Ferring BV Product
Table 51. Ferring BV Recent Development
Table 52. Merck KGaA Corporation Information
Table 53. Merck KGaA Description and Business Overview
Table 54. Merck KGaA Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Merck KGaA Product
Table 56. Merck KGaA Recent Development
Table 57. Novartis AG Corporation Information
Table 58. Novartis AG Description and Business Overview
Table 59. Novartis AG Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Novartis AG Product
Table 61. Novartis AG Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Female Infertility Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Female Infertility Drugs Customers List
Table 70. Female Infertility Drugs Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Infertility Drugs Product Picture
Figure 2. Global Female Infertility Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Female Infertility Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Female Infertility Drugs Sales 2017-2028 (K Units)
Figure 5. United States Female Infertility Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Female Infertility Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Female Infertility Drugs Sales 2017-2028 (K Units)
Figure 8. United States Female Infertility Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Female Infertility Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Female Infertility Drugs Report Years Considered
Figure 11. Product Picture of Parenteral
Figure 12. Product Picture of Oral
Figure 13. Product Picture of Others
Figure 14. Global Female Infertility Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Female Infertility Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Female Infertility Drugs Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Female Infertility Drugs Sales by Type (2017-2028) & (K Units)
Figure 18. Global Female Infertility Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Female Infertility Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Female Infertility Drugs Market Share by Type in 2022 & 2028
Figure 21. United States Female Infertility Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Female Infertility Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Female Infertility Drugs Sales by Type (2017-2028) & (K Units)
Figure 24. United States Female Infertility Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Female Infertility Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Fertility Clinics
Figure 27. Product Picture of Hospitals
Figure 28. Product Picture of Cryobanks
Figure 29. Global Female Infertility Drugs Market Share by Application in 2022 & 2028
Figure 30. Global Female Infertility Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Female Infertility Drugs Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Female Infertility Drugs Sales by Application (2017-2028) & (K Units)
Figure 33. Global Female Infertility Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Female Infertility Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Female Infertility Drugs Market Share by Application in 2022 & 2028
Figure 36. United States Female Infertility Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Female Infertility Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Female Infertility Drugs Sales by Application (2017-2028) & (K Units)
Figure 39. United States Female Infertility Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Female Infertility Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Female Infertility Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Female Infertility Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Female Infertility Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Female Infertility Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Female Infertility Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Female Infertility Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Female Infertility Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Female Infertility Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Female Infertility Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Female Infertility Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Female Infertility Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Female Infertility Drugs Value Chain
Figure 75. Female Infertility Drugs Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Industry Market Size
